Correlation Between Mereo BioPharma and Lipella Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Lipella Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Lipella Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and Lipella Pharmaceuticals Common, you can compare the effects of market volatilities on Mereo BioPharma and Lipella Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Lipella Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Lipella Pharmaceuticals.
Diversification Opportunities for Mereo BioPharma and Lipella Pharmaceuticals
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mereo and Lipella is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Lipella Pharmaceuticals Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipella Pharmaceuticals and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Lipella Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipella Pharmaceuticals has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Lipella Pharmaceuticals go up and down completely randomly.
Pair Corralation between Mereo BioPharma and Lipella Pharmaceuticals
Given the investment horizon of 90 days Mereo BioPharma Group is expected to generate 0.46 times more return on investment than Lipella Pharmaceuticals. However, Mereo BioPharma Group is 2.15 times less risky than Lipella Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Lipella Pharmaceuticals Common is currently generating about 0.01 per unit of risk. If you would invest 85.00 in Mereo BioPharma Group on November 27, 2024 and sell it today you would earn a total of 184.00 from holding Mereo BioPharma Group or generate 216.47% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mereo BioPharma Group vs. Lipella Pharmaceuticals Common
Performance |
| Timeline |
| Mereo BioPharma Group |
| Lipella Pharmaceuticals |
Mereo BioPharma and Lipella Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mereo BioPharma and Lipella Pharmaceuticals
The main advantage of trading using opposite Mereo BioPharma and Lipella Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Lipella Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipella Pharmaceuticals will offset losses from the drop in Lipella Pharmaceuticals' long position.| Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
| Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |